Open-label Clinical Trial to Evaluate the Efficacy of Sodium Oxybate (Xyrem) in the Treatment of Two Under-recognized Clinical Conditions: Post-traumatic Narcolepsy and Post-traumatic Hypersomnia
Phase of Trial: Phase 0
Latest Information Update: 15 Feb 2019
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Hypersomnia; Narcolepsy
- Focus Therapeutic Use
- 07 Feb 2019 Planned initiation date changed from 1 Oct 2018 to 1 Mar 2019.
- 12 Nov 2018 Status changed from not yet recruiting to recruiting.
- 28 Aug 2018 Planned primary completion date changed from 1 Aug 2020 to 1 Oct 2020.